Agilent Technologies Inc (A):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Agilent Technologies Inc (A) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7233)・商品コード:DATA904C7233
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The company serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers’ representatives, resellers and e-commerce. It has research and development (R&D) and manufacturing facilities in the US, the UK, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc (A) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Agilent Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Agilent Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Agilent Technologies Inc, Medical Equipment, Deal Details 16
Asset Purchase 16
Agilent Technologies to Acquire Agilent-Related Business from Young In Scientific 16
Agilent Technologies to Reacquire Assets of Varian 17
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies 18
Dako To Acquire Intellectual Property Rights From System Dynamics 19
Venture Financing 20
NanoCellect Biomedical Raises USD10 Million in Series B Financing 20
Private Equity 21
Agilent Technologies Recommends Stockholders to Reject Mini-Tender Offer of TRC Capital 21
Partnerships 22
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 22
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 23
Agilent Technologies Enters into Agreement with University of Southern California 24
Agilent Technologies and Agendia Enter into Agreement 25
Luxcel Biosciences and HD Biosciences Enter into Agreement 26
Agilent Technologies Enters into Agreement with Burning Rock Biotech 27
Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging 28
Agilent Technologies Enters into Agreement with Eurofins Genomics 29
Agilent Technologies Enters into Agreement with 10X Genomics 30
Protea Biosciences Enters into Agreement with Agilent Technologies 31
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 32
Merck and Pfizer Enters into Agreement with Dako 33
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 34
Population Genetics Enters into Agreement with Case Western Reserve University to Develop Diagnostics Technology 35
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 36
Agilent Extends Co-Marketing Agreement with MRM Proteomics 37
Dako Enters into Agreement with Merck for Companion Diagnostic Test 38
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 39
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 40
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 41
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 42
Agilent Enters Into Research Agreement With Chungnam National University 43
Agilent Technologies Enters Into Co-Development Agreement With Florida International University 44
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 45
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics 46
Agilent Technologies Enters Into Research Agreement With Ameritox 47
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 48
Advion Enters Into Technology Integration Agreement With Agilent Technologies 49
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery 50
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics 51
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers 52
Dako Enters Into Co-Development Agreement With Amgen 53
Dako Enters Into Co-Development Agreement With Amgen 54
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 55
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 56
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 57
Debt Offering 58
Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026 58
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million 59
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 61
Asset Transactions 63
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies 63
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 64
Acquisition 65
Agilent Technologies to Acquire ACEA Biosciences for USD250 Million 65
Agilent Technologies Acquires Lasergen for USD105 Million 66
Agilent Technologies to Acquire Genohm 67
Agilent Technologies to Acquire Advanced Analytical Technologies for USD250 Million 68
Agilent Technologies Acquires Luxcel Biosciences 69
Agilent Technologies Acquires Multiplicom for USD72 Million 70
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 71
Agilent Technologies Acquires Seahorse Bioscience for USD242 Million 72
Agilent Technologies Acquires Cartagenia for USD68.34 Million 73
Agilent Technologies To Acquire ABC Instrumentacion Analitica 74
Leica Biosystems Completes Acquisition Of Aperio Technologies 75
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 77
Agilent Technologies Inc – Key Competitors 79
Agilent Technologies Inc – Key Employees 80
Agilent Technologies Inc – Locations And Subsidiaries 81
Head Office 81
Other Locations & Subsidiaries 81
Recent Developments 83
Strategy And Business Planning 83
May 04, 2018: Agilent Expands Logistics Center in Texas 83
Apr 27, 2018: Agilent Opens Global Solution Development Center in Singapore 84
Apr 04, 2018: Agilent and BioTek Join Forces to Create an Integrated Metabolic Analysis and Imaging Platform 85
Jul 07, 2017: Agilent Technologies Opens New Customer & Technology Center in Waldbronn, Germany 86
Financial Announcements 87
Aug 14, 2018: Agilent Technologies reports third-quarter fiscal year 2018 financial results 87
May 14, 2018: Agilent Reports Second-Quarter Fiscal Year 2018 Financial Results 89
Feb 14, 2018: Agilent Technologies Reports First-Quarter Fiscal Year 2018 Financial Results 90
Nov 20, 2017: Agilent Technologies Reports Fourth-Quarter Fiscal Year 2017 Financial Results 91
Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results 92
May 22, 2017: Agilent Technologies Reports Second-Quarter Fiscal Year 2017 Financial Results 93
Feb 14, 2017: Agilent Technologies Reports First-Quarter 2017 Results 94
Corporate Communications 95
Jul 31, 2018: Agilent announces CFO transition 95
Apr 24, 2018: Agilent Announces Executive Appointments 96
Apr 16, 2018: Agilent Announces Departure of Patrick Kaltenbach 97
Jan 18, 2018: Agilent Technologies Appoints Dow R. Wilson As Board Director 98
Jan 18, 2018: Dow R. Wilson to Join Agilent’s Board of Directors 99
Jul 18, 2017: Hans E. Bishop to Join Agilent’s Board of Directors 100
May 04, 2017: Agilent Technologies Receives Multiple Awards at Scientific Conference in China 101
Mar 20, 2017: Agilent Technologies Hires Samraat “Sam” Raha to Head Strategy and Corporate Development 102
Mar 15, 2017: Agilent Technologies Board of Directors Elects Koh Boon Hwee as New Chairman 103
Mar 14, 2017: Agilent Technologies Receives 2017 Scientists’ Choice Award for Best Webinar Series 104
Feb 21, 2017: Agilent Technologies Receives Dow’s Western Canada Science and Technical Excellence Conference Awards (WesTEC) for Technical Excellence and Innovation 105
Legal and Regulatory 106
Jan 11, 2017: Applied Spectral Imaging announced that its GenASIs applications comply with CE-IVD requirements with the IQFISH lung cancer panel on Dako Omnis of Agilent Technologies 106
Government and Public Interest 107
Sep 18, 2018: Twist Bioscience Responds to Agilent’s Latest Specious Claims 107
Product News 108
Jun 14, 2018: Agilent Expands Portfolio of Probes for In Situ Hybridization 108
Jun 01, 2018: Agilent Demonstrates ‘Innovation with Purpose’ at ASMS 2018 109
Apr 09, 2018: Agilent Highlights Lab Efficiency through Innovative Solutions at Analytica 2018 110
Mar 15, 2018: Agilent Introduces New Color for Cancer Diagnosis 111
Jun 19, 2017: Agilent Technologies Unveils New Analytical and Purification Solutions at HPLC 2017 112
Jun 05, 2017: Prosolia DESI 2D Molecular Imaging Now Compatible with Agilent Technologies 113
Other Significant Developments 114
Jun 04, 2018: Agilent Insources to Optimize Logistics Operations 114
Feb 28, 2018: Agilent and Imperial College London Announce Collaboration Agreement 115
Feb 08, 2018: Agilent to Support Korea Doping Control Center 116
Appendix 117
Methodology 117
About GlobalData 117
Contact Us 117
Disclaimer 117

List of Tables
Agilent Technologies Inc, Medical Equipment, Key Facts, 2017 2
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Agilent Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Agilent Technologies Inc, Deals By Market, 2012 to YTD 2018 11
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Agilent Technologies to Acquire Agilent-Related Business from Young In Scientific 16
Agilent Technologies to Reacquire Assets of Varian 17
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies 18
Dako To Acquire Intellectual Property Rights From System Dynamics 19
NanoCellect Biomedical Raises USD10 Million in Series B Financing 20
Agilent Technologies Recommends Stockholders to Reject Mini-Tender Offer of TRC Capital 21
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 22
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 23
Agilent Technologies Enters into Agreement with University of Southern California 24
Agilent Technologies and Agendia Enter into Agreement 25
Luxcel Biosciences and HD Biosciences Enter into Agreement 26
Agilent Technologies Enters into Agreement with Burning Rock Biotech 27
Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging 28
Agilent Technologies Enters into Agreement with Eurofins Genomics 29
Agilent Technologies Enters into Agreement with 10X Genomics 30
Protea Biosciences Enters into Agreement with Agilent Technologies 31
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 32
Merck and Pfizer Enters into Agreement with Dako 33
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 34
Population Genetics Enters into Agreement with Case Western Reserve University to Develop Diagnostics Technology 35
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 36
Agilent Extends Co-Marketing Agreement with MRM Proteomics 37
Dako Enters into Agreement with Merck for Companion Diagnostic Test 38
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 39
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 40
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 41
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 42
Agilent Enters Into Research Agreement With Chungnam National University 43
Agilent Technologies Enters Into Co-Development Agreement With Florida International University 44
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 45
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics 46
Agilent Technologies Enters Into Research Agreement With Ameritox 47
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 48
Advion Enters Into Technology Integration Agreement With Agilent Technologies 49
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery 50
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics 51
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers 52
Dako Enters Into Co-Development Agreement With Amgen 53
Dako Enters Into Co-Development Agreement With Amgen 54
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 55
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 56
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 57
Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026 58
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million 59
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 61
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies 63
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 64
Agilent Technologies to Acquire ACEA Biosciences for USD250 Million 65
Agilent Technologies Acquires Lasergen for USD105 Million 66
Agilent Technologies to Acquire Genohm 67
Agilent Technologies to Acquire Advanced Analytical Technologies for USD250 Million 68
Agilent Technologies Acquires Luxcel Biosciences 69
Agilent Technologies Acquires Multiplicom for USD72 Million 70
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 71
Agilent Technologies Acquires Seahorse Bioscience for USD242 Million 72
Agilent Technologies Acquires Cartagenia for USD68.34 Million 73
Agilent Technologies To Acquire ABC Instrumentacion Analitica 74
Leica Biosystems Completes Acquisition Of Aperio Technologies 75
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 77
Agilent Technologies Inc, Key Competitors 79
Agilent Technologies Inc, Key Employees 80
Agilent Technologies Inc, Subsidiaries 81

List of Figures
Agilent Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Agilent Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Agilent Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Agilent Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

★調査レポート[Agilent Technologies Inc (A):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C7233)販売に関する免責事項を必ずご確認ください。
★調査レポート[Agilent Technologies Inc (A):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆